MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: Schuheدهانات المدينة مصراتةAntwortenAntworten: دهانات المدينة مصراتة <blockquote><div class="quotetitle">Zitat von Gast am 24. März 2026, 14:21 Uhr</div>[url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey= ]Zoya Demidenko[/url]: Scientist in Tumor Studies [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord ]Zoya Demidenko[/url] is a distinguished investigator affiliated with the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Earlier, she was employed at the National Institutes of Health and New York Medical College, developing a robust background in biomedical study. Her scholarly output encompasses multiple critical domains, encompassing the PI3K/AKT/mTOR signaling pathway, cellular cycle control, cellular aging, and tumor biology. To date, she has co-authored over 46 academic articles, which have accumulated more than 4,100 citations — a reflection to the significance of her research. Among her most notable discoveries concerns explaining the mechanisms of biological cell aging. Her research showed that when the cellular division cycle is arrested but cellular expansion continues, cells enter senescence. Crucially, [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012 ]Zoya Demidenko[/url] demonstrated that this shift can be inhibited by medication using agents such as rapamycin. [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord ]Zoya Demidenko[/url] has additionally contributed substantially to oncological therapy investigation, particularly in the field of selective cell protection — a method designed to protecting non-cancerous cells from anticancer drugs while leaving tumor cells exposed. This strategy carries significant hope for reducing the adverse effects of oncological therapy. Throughout her professional journey, Demidenko has partnered with prominent investigators internationally, such as Dr. Mikhail Blagosklonny. Her research is published in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. With an h-index of 33, [url=https://www.pinterest.com/zoyademidenko/ ]Zoya Demidenko[/url] is recognized as a influential figure in modern biomedical research, with her results keep to shape our comprehension of the way cells age, interact with therapy, and the ways in which malignant disease might be better treated. https://www.oncotarget.com/article/4836/ </blockquote><br> Abbrechen
